Posts by Rebecca Israel, MD
-
tPA for Refractory ARDS in COVID-19: Clinical Trials Needed to Evaluate Efficacy
Although ARDS is associated with hypercoagulability, more data is needed to evaluate efficacy of therapeutic anticoagulation or a fibrinolytic in improving patient outcomes in COVID-19.
-
Coagulation and ARDS in COVID-19
Tonight's FLARE will discuss the relationship between coagulation and ARDS and apply this to a recently proposed intervention for patients with severe COVID-19.
-
FAQs, GI Disease, Washington and Italy
This FLARE will cover FAQs about the Mass General Critical Care Guidance, COVID-19 presenting as GI disease and analysis of newly published clinical data.